Nathalie Dubois-Stringfellow
CIK 1947007 · SVP-CHIEF DEVELOPMENT OFFICER · last filed 2026-05-27
Nathalie Dubois-Stringfellow is a SVP-CHIEF DEVELOPMENT OFFICER who has filed 22 SEC Form 4 insider transactions across 1 company since 2023. Across all open-market trades the lifetime net is −$89.2K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
22
-$89.2K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SANGAMO THERAPEUTICS, INC (SGMO) Delisted | SVP-CHIEF DEVELOPMENT OFFICER | 332,769 | $0.18 | $59.1K | -$89.2K | 21 | 2026-04-23 |
Recent Filings
22 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-27 | — | Tax (F) | −4,036 | -$703 | |
| 2026-04-23 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Sell (S) | −345,942 | -$89.2K | EDGAR |
| 2026-04-03 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2026-02-26 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Tax (F) | −14,417 | -$6.8K | EDGAR |
| 2026-01-26 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Tax (F) | −36,676 | -$14.6K | EDGAR |
| 2025-11-26 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Tax (F) | −2,544 | -$1.1K | EDGAR |
| 2025-10-24 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Tax (F) | −43,741 | -$28.9K | EDGAR |
| 2025-08-26 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Tax (F) | −1,792 | -$1.1K | EDGAR |
| 2025-07-24 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Tax (F) | −31,866 | -$15.3K | EDGAR |
| 2025-05-28 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Tax (F) | −1,792 | -$848 | EDGAR |